Metropolitan Life Insurance Company (MetLife)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-13,378
| Closed | -$1.43M | – | 1315 |
|
2024
Q1 | $1.43M | Sell |
13,378
-123
| -0.9% | -$13.1K | 0.06% | 266 |
|
2023
Q4 | $1.34M | Sell |
13,501
-198
| -1% | -$19.7K | 0.06% | 272 |
|
2023
Q3 | $1.41M | Sell |
13,699
-588
| -4% | -$60.7K | 0.07% | 237 |
|
2023
Q2 | $1.74M | Sell |
14,287
-490
| -3% | -$59.5K | 0.08% | 208 |
|
2023
Q1 | $2.27M | Sell |
14,777
-3,557
| -19% | -$546K | 0.12% | 154 |
|
2022
Q4 | $3.29M | Sell |
18,334
-984
| -5% | -$177K | 0.15% | 139 |
|
2022
Q3 | $2.28M | Sell |
19,318
-796
| -4% | -$94.1K | 0.11% | 181 |
|
2022
Q2 | $2.87M | Sell |
20,114
-914
| -4% | -$131K | 0.13% | 156 |
|
2022
Q1 | $3.62M | Sell |
21,028
-34,053
| -62% | -$5.87M | 0.13% | 152 |
|
2021
Q4 | $14M | Sell |
55,081
-1,503
| -3% | -$382K | 0.19% | 90 |
|
2021
Q3 | $21.8M | Buy |
56,584
+33,128
| +141% | +$12.7M | 0.32% | 56 |
|
2021
Q2 | $5.51M | Buy |
23,456
+2,695
| +13% | +$633K | 0.08% | 197 |
|
2021
Q1 | $2.72M | Sell |
20,761
-934
| -4% | -$122K | 0.04% | 384 |
|
2020
Q4 | $2.27M | Sell |
21,695
-423
| -2% | -$44.2K | 0.03% | 428 |
|
2020
Q3 | $1.56M | Buy |
22,118
+770
| +4% | +$54.5K | 0.03% | 511 |
|
2020
Q2 | $1.37M | Buy |
21,348
+6,710
| +46% | +$431K | 0.02% | 561 |
|
2020
Q1 | $438K | Buy |
14,638
+659
| +5% | +$19.7K | 0.01% | 1122 |
|
2019
Q4 | $273K | Sell |
13,979
-67
| -0.5% | -$1.31K | ﹤0.01% | 1707 |
|
2019
Q3 | $224K | Buy |
14,046
+12,233
| +675% | +$195K | ﹤0.01% | 1801 |
|
2019
Q2 | $26.5K | Sell |
1,813
-40
| -2% | -$586 | ﹤0.01% | 2573 |
|
2019
Q1 | $37.7K | Buy |
+1,853
| New | +$37.7K | ﹤0.01% | 2517 |
|